세계의 심장 재동기화치료(CRT) 기기 시장 : 시장 규모, 점유율, 동향 분석, 기회 예측 보고서(2019-2030년)

Global Cardiac Resynchronization Therapy (CRT) Devices Market Size Booming at Healthy CAGR of 8.4% to Touch USD 11.6 Billion by 2030

Global Cardiac Resynchronization Therapy (CRT) Devices Market is growing due to heart failure prevalence, device tech advances, aging population, and increased awareness, boosting CRT device usage worldwide.

BlueWeave Consulting, a leading strategic consulting, and Market research firm, in its recent study, estimated the Global Cardiac Resynchronization Therapy (CRT) Devices Market size by value at USD 6.59 billion in 2023. During the forecast period between 2024 and 2030, BlueWeave expects the Global Cardiac Resynchronization Therapy (CRT) Devices Market size to expand at a CAGR of 8.4% reaching a value of USD 11.59 billion in 2030. The Global Cardiac Resynchronization Therapy (CRT) Devices Market is driven by the increasing burden of heart failure and cardiac disorders, the geriatric population, and the sedentary lifestyle. The global population is aging rapidly, leading to reduced birth rates and increased life expectancy. The geriatric population's rise in cardiovascular and heart failure cases increases the demand for CRT, boosting market growth during the period in analysis.

Opportunity - Growing adoption of Big Data in healthcare

The Global Market for Cardiac Resynchronization Therapy (CRT) Devices is prospering as a result of proactive measures incorporated by major healthcare businesses. These measures include accelerating product development, broadening market reach, and improving patient outcomes. Major corporations are focused on sophisticated technologies to develop breakthrough goods for cardiac patients. They also work with healthcare providers and academic organizations on clinical research. These firms are extending their market presence through strategic collaborations and marketing activities, to improve global patient access to CRT devices and drive market growth.

Impact of Escalating Geopolitical Tensions on Global Cardiac Resynchronization Therapy (CRT) Devices Market

Intensifying geopolitical tensions across regions impact the Global Cardiac Resynchronization Therapy (CRT) Devices Market through supply chain disruptions, trade restrictions affecting essential technologies, increased costs due to unstable currency exchange rates, slowed innovation from uncertain R&D investments, and reduced market size in regions with unstable healthcare infrastructure.

Global Cardiac Resynchronization Therapy (CRT) Devices Market

Segmental Coverage

Global Cardiac Resynchronization Therapy (CRT) Devices Market - By Product Type

Based on product type, Global Cardiac Resynchronization Therapy (CRT) Devices Market is split into CRT-Pacemakers and CRT-Defibrillators segments. CRT-D devices dominate the market. CRT-D devices synchronize heart rhythm and provide life-saving defibrillation shocks. Their dual functionality is preferred for high risk patients. Advancements in technology like improved battery life increase adoption. CRT-D devices, despite being costly and complex, have a larger market share due to their critical role in severe cardiac conditions.

Global Cardiac Resynchronization Therapy (CRT) Devices Market - By Age

Based on age, the Global Cardiac Resynchronization Therapy (CRT) Devices Market is divided into Below 44 years, 45-64 years, 65-84 years, and Above 85 years segments. The 65-84 age group dominates the Global CRT Devices Market due to its high heart-related conditions. Aging populations in developed countries drive this trend as cardiovascular issues rise with age. This group's access to healthcare contributes to CRT device adoption, influencing market dynamics and prompting manufacturers to focus on tailored innovations for older patients.

Competitive Landscape

The Global Cardiac Resynchronization Therapy (CRT) Devices Market is fiercely competitive. Major companies in the market include Medtronic, Abbott, Boston Scientific Corporation, Biotronik, MicroPort Scientific Corporation, Livanova plc, Integer Holdings Corporation, Lepu Medical Technology Co., Ltd, Mayo Clinic, and Osypka Medical. These companies use various strategies, including increasing investments in their R&D activities, mergers, and acquisitions, joint ventures, collaborations, licensing agreements, and new product and service releases to further strengthen their position in the Global Cardiac Resynchronization Therapy (CRT) Devices Market.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of the Global Cardiac Resynchronization Therapy (CRT) Devices Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Cardiac Resynchronization Therapy (CRT) Devices Market and industry insights to help decision-makers make sound strategic decisions. Further, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

• 1.1. Research Objective
• 1.2. Product Overview
• 1.3. Market Segmentation

2. Executive Summary

3. Global Cardiac Resynchronization Therapy (CRT) Devices Market Insights

• 3.1. End Use Value Chain Analysis
• 3.2. DROC Analysis
  • 3.2.1. Growth Drivers
    • 3.2.1.1. Rising incidence of cardiovascular disorders
    • 3.2.1.2. Growing geriatric population
    • 3.2.1.3. Increasing advancements in product technology
    • 3.2.1.4. Expanding medical infrastructure and favorable financial conditions in developing regions
  • 3.2.2. Restraints
    • 3.2.2.1. High cost of CRT devices and implantation procedures
    • 3.2.2.2. Stringent regulatory scenario
    • 3.2.2.3. Lack of awareness among patients and healthcare providers about the benefits of CRT
  • 3.2.3. Opportunities
    • 3.2.3.1. Increasing adoption of new technology
    • 3.2.3.2. Rising initiatives by major companies
    • 3.2.3.3. Increasing adoption of minimally invasive procedures
  • 3.2.4. Challenges
    • 3.2.4.1. Complexity of device implantation
    • 3.2.4.2. Competition from alternative therapies
• 3.3. Technological Advancements/Recent Developments
• 3.4. Regulatory Framework
• 3.5. Porter's Five Forces Analysis
  • 3.5.1. Bargaining Power of Suppliers
  • 3.5.2. Bargaining Power of Buyers
  • 3.5.3. Threat of New Entrants
  • 3.5.4. Threat of Substitutes
  • 3.5.5. Intensity of Rivalry

4. Global Cardiac Resynchronization Therapy (CRT) Devices Market: Marketing Strategies

5. Global Cardiac Resynchronization Therapy (CRT) Devices Market: Pricing Analysis

6. Global Cardiac Resynchronization Therapy (CRT) Devices Market: Geography Analysis

• 6.1. Global Cardiac Resynchronization Therapy (CRT) Devices Market, Geographical Analysis, 2023
• 6.2. Global Cardiac Resynchronization Therapy (CRT) Devices, Market Attractiveness Analysis, 2024-2030

7. Global Cardiac Resynchronization Therapy (CRT) Devices Market Overview

• 7.1. Market Size & Forecast, 2019-2030
  • 7.1.1. By Value (USD Million)
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
    • 7.2.1.1. CRT-Pacemakers
    • 7.2.1.2. CRT-Defibrillators
  • 7.2.2. By Age
    • 7.2.2.1. Below 44 years
    • 7.2.2.2. 45-64 years
    • 7.2.2.3. 65-84 years
    • 7.2.2.4. Above 85 years
  • 7.2.3. By End Use
    • 7.2.3.1. Hospitals
    • 7.2.3.2. Cardiac care centers
    • 7.2.3.3. Ambulatory surgical centers
    • 7.2.3.4. Others
  • 7.2.4. By Region
    • 7.2.4.1. North America
    • 7.2.4.2. Europe
    • 7.2.4.3. Asia Pacific (APAC)
    • 7.2.4.4. Latin America (LATAM)
    • 7.2.4.5. Middle East and Africa (MEA)

8. North America Cardiac Resynchronization Therapy (CRT) Devices Market

• 8.1. Market Size & Forecast, 2019-2030
  • 8.1.1. By Value (USD Million)
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By Age
  • 8.2.3. By End Use
  • 8.2.4. By Country
    • 8.2.4.1. United States
    • 8.2.4.1.1. By Product Type
    • 8.2.4.1.2. By Age
    • 8.2.4.1.3. By End Use
    • 8.2.4.2. Canada
    • 8.2.4.2.1. By Product Type
    • 8.2.4.2.2. By Age
    • 8.2.4.2.3. By End Use

9. Europe Cardiac Resynchronization Therapy (CRT) Devices Market

• 9.1. Market Size & Forecast, 2019-2030
  • 9.1.1. By Value (USD Million)
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By Age
  • 9.2.3. By End Use
  • 9.2.4. By Country
    • 9.2.4.1. Germany
    • 9.2.4.1.1. By Product Type
    • 9.2.4.1.2. By Age
    • 9.2.4.1.3. By End Use
    • 9.2.4.2. United Kingdom
    • 9.2.4.2.1. By Product Type
    • 9.2.4.2.2. By Age
    • 9.2.4.2.3. By End Use
    • 9.2.4.3. Italy
    • 9.2.4.3.1. By Product Type
    • 9.2.4.3.2. By Age
    • 9.2.4.3.3. By End Use
    • 9.2.4.4. France
    • 9.2.4.4.1. By Product Type
    • 9.2.4.4.2. By Age
    • 9.2.4.4.3. By End Use
    • 9.2.4.5. Spain
    • 9.2.4.5.1. By Product Type
    • 9.2.4.5.2. By Age
    • 9.2.4.5.3. By End Use
    • 9.2.4.6. Belgium
    • 9.2.4.6.1. By Product Type
    • 9.2.4.6.2. By Age
    • 9.2.4.6.3. By End Use
    • 9.2.4.7. Russia
    • 9.2.4.7.1. By Product Type
    • 9.2.4.7.2. By Age
    • 9.2.4.7.3. By End Use
    • 9.2.4.8. The Netherlands
    • 9.2.4.8.1. By Product Type
    • 9.2.4.8.2. By Age
    • 9.2.4.8.3. By End Use
    • 9.2.4.9. Rest of Europe
    • 9.2.4.9.1. By Product Type
    • 9.2.4.9.2. By Age
    • 9.2.4.9.3. By End Use

10. Asia Pacific Cardiac Resynchronization Therapy (CRT) Devices Market

• 10.1. Market Size & Forecast, 2019-2030
  • 10.1.1. By Value (USD Million)
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By Age
  • 10.2.3. By End Use
  • 10.2.4. By Country
    • 10.2.4.1. China
    • 10.2.4.1.1. By Product Type
    • 10.2.4.1.2. By Age
    • 10.2.4.1.3. By End Use
    • 10.2.4.2. India
    • 10.2.4.2.1. By Product Type
    • 10.2.4.2.2. By Age
    • 10.2.4.2.3. By End Use
    • 10.2.4.3. Japan
    • 10.2.4.3.1. By Product Type
    • 10.2.4.3.2. By Age
    • 10.2.4.3.3. By End Use
    • 10.2.4.4. South Korea
    • 10.2.4.4.1. By Product Type
    • 10.2.4.4.2. By Age
    • 10.2.4.4.3. By End Use
    • 10.2.4.5. Australia & New Zealand
    • 10.2.4.5.1. By Product Type
    • 10.2.4.5.2. By Age
    • 10.2.4.5.3. By End Use
    • 10.2.4.6. Indonesia
    • 10.2.4.6.1. By Product Type
    • 10.2.4.6.2. By Age
    • 10.2.4.6.3. By End Use
    • 10.2.4.7. Malaysia
    • 10.2.4.7.1. By Product Type
    • 10.2.4.7.2. By Age
    • 10.2.4.7.3. By End Use
    • 10.2.4.8. Singapore
    • 10.2.4.8.1. By Product Type
    • 10.2.4.8.2. By Age
    • 10.2.4.8.3. By End Use
    • 10.2.4.9. Vietnam
    • 10.2.4.9.1. By Product Type
    • 10.2.4.9.2. By Age
    • 10.2.4.9.3. By End Use
    • 10.2.4.10. Rest of APAC
    • 10.2.4.10.1. By Product Type
    • 10.2.4.10.2. By Age
    • 10.2.4.10.3. By End Use

11. Latin America Cardiac Resynchronization Therapy (CRT) Devices Market

• 11.1. Market Size & Forecast, 2019-2030
  • 11.1.1. By Value (USD Million)
• 11.2. Market Share & Forecast
  • 11.2.1. By Product Type
  • 11.2.2. By Age
  • 11.2.3. By End Use
  • 11.2.4. By Country
    • 11.2.4.1. Brazil
    • 11.2.4.1.1. By Product Type
    • 11.2.4.1.2. By Age
    • 11.2.4.1.3. By End Use
    • 11.2.4.2. Mexico
    • 11.2.4.2.1. By Product Type
    • 11.2.4.2.2. By Age
    • 11.2.4.2.3. By End Use
    • 11.2.4.3. Argentina
    • 11.2.4.3.1. By Product Type
    • 11.2.4.3.2. By Age
    • 11.2.4.3.3. By End Use
    • 11.2.4.4. Peru
    • 11.2.4.4.1. By Product Type
    • 11.2.4.4.2. By Age
    • 11.2.4.4.3. By End Use
    • 11.2.4.5. Rest of LATAM
    • 11.2.4.5.1. By Product Type
    • 11.2.4.5.2. By Age
    • 11.2.4.5.3. By End Use

12. Middle East & Africa Cardiac Resynchronization Therapy (CRT) Devices Market

• 12.1. Market Size & Forecast, 2019-2030
  • 12.1.1. By Value (USD Million)
• 12.2. Market Share & Forecast
  • 12.2.1. By Product Type
  • 12.2.2. By Age
  • 12.2.3. By End Use
  • 12.2.4. By Country
    • 12.2.4.1. Saudi Arabia
    • 12.2.4.1.1. By Product Type
    • 12.2.4.1.2. By Age
    • 12.2.4.1.3. By End Use
    • 12.2.4.2. UAE
    • 12.2.4.2.1. By Product Type
    • 12.2.4.2.2. By Age
    • 12.2.4.2.3. By End Use
    • 12.2.4.3. Qatar
    • 12.2.4.3.1. By Product Type
    • 12.2.4.3.2. By Age
    • 12.2.4.3.3. By End Use
    • 12.2.4.4. Kuwait
    • 12.2.4.4.1. By Product Type
    • 12.2.4.4.2. By Age
    • 12.2.4.4.3. By End Use
    • 12.2.4.5. South Africa
    • 12.2.4.5.1. By Product Type
    • 12.2.4.5.2. By Age
    • 12.2.4.5.3. By End Use
    • 12.2.4.6. Nigeria
    • 12.2.4.6.1. By Product Type
    • 12.2.4.6.2. By Age
    • 12.2.4.6.3. By End Use
    • 12.2.4.7. Algeria
    • 12.2.4.7.1. By Product Type
    • 12.2.4.7.2. By Age
    • 12.2.4.7.3. By End Use
    • 12.2.4.8. Rest of MEA
    • 12.2.4.8.1. By Product Type
    • 12.2.4.8.2. By Age
    • 12.2.4.8.3. By End Use

13. Competitive Landscape

• 13.1. List of Key Players and Their Offerings
• 13.2. Global Cardiac Resynchronization Therapy (CRT) Devices Company Market Share Analysis, 2023
• 13.3. Competitive Benchmarking, By Operating Parameters
• 13.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

14. Impact of Escalating Geopolitical Tensions on Global Cardiac Resynchronization Therapy (CRT) Devices Market

15. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)

• 15.1. Medtronic
• 15.2. Abbott
• 15.3. Boston Scientific Corporation
• 15.4. Biotronik
• 15.5. MicroPort Scientific Corporation
• 15.6. Livanova plc
• 15.7. Integer Holdings Corporation
• 15.8. Lepu Medical Technology Co Ltd
• 15.9. Mayo Clinic
• 15.10. Osypka Medical
• 15.11. Other Prominent Players

16. Key Strategic Recommendations

17. Research Methodology

• 17.1. Qualitative Research
  • 17.1.1. Primary & Secondary Research
• 17.2. Quantitative Research
• 17.3. Market Breakdown & Data Triangulation
  • 17.3.1. Secondary Research
  • 17.3.2. Primary Research
• 17.4. Breakdown of Primary Research Respondents, By Region
• 17.5. Assumptions & Limitations

*Financial information of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable